Testagen — Khavinson bioregulator — testes / male reproductive
Testagen targets testicular Leydig and Sertoli cells. Proposed to restore testosterone biosynthesis gene expression (StAR, CYP11A1, CYP17A1), improve spermatogenesis, and support age-related testosterone decline. Very limited published human data.
Overview
This page is part of Hormonaly's evidence-graded compound library. All clinical claims are linked to peer-reviewed sources via our dual-layer citation verification pipeline.
Compound Class
Khavinson bioregulator — testes / male reproductive
Mechanism of Action
Testagen targets testicular Leydig and Sertoli cells. Proposed to restore testosterone biosynthesis gene expression (StAR, CYP11A1, CYP17A1), improve spermatogenesis, and support age-related testosterone decline. Very limited published human data.
Regulatory Status
Not FDA approved. Research peptide.
Evidence Level
Very Low — theoretical mechanism supported by Khavinson bioregulator framework; minimal published human clinical data.